Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.062 AUD | +8.77% | -13.89% | -10.14% |
08:53am | Easing Rate Hike Concerns Shore Up Australian Shares | MT |
06:42am | Neurotech's Extended NTI164 Drug Trial Yields Further Improvements; Shares Surge Nearly 11% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-10.14% | 38.5M | |
+55.70% | 59.34B | |
+42.72% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+2.72% | 12.49B | |
+25.85% | 12.28B |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International : Completes Preclinical Studies of Medical Cannabis in Multiple Sclerosis; Shares Jump 7%